DERMABOND Portfolio
Device
Ethicon Inc.
Total Payments
$1.2M
Transactions
2,163
Doctors
1,531
Companies
8
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $467,322 | 328 | 183 |
| 2019 | $343,540 | 465 | 348 |
| 2018 | $265,034 | 885 | 677 |
| 2017 | $93,682 | 485 | 412 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $947,559 | 253 | 81.0% |
| Unspecified | $113,979 | 10 | 9.7% |
| Food and Beverage | $65,686 | 1,780 | 5.6% |
| Travel and Lodging | $32,909 | 87 | 2.8% |
| Space rental or facility fees (teaching hospital only) | $5,350 | 9 | 0.5% |
| Education | $2,096 | 21 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,000 | 3 | 0.2% |
Payments by Type
General
$1.1M
2,153 transactions
Research
$113,979
10 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Investigation of a New Skin Closure Device, Dermabond PRINEO, for Total Shoulder Arthroplasty: A Randomized, Controlled Trial (US) | Ethicon Inc. | $60,300 | 0 |
| The use of Dermabond Prineo Wound closure system compared to standard-of-care for superficial tissue closure in total knee arthroplasty | Medical Device Business Services, Inc. | $50,552 | 0 |
| Use of Prineo for Wound Closure in Breast Reduction Surgery | Medical Device Business Services, Inc. | $3,128 | 0 |
Top Doctors Receiving Payments for DERMABOND Portfolio — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Seattle, WA | $5,330 | 2 |
| , MD | Orthopaedic Surgery | Ft Myers, FL | $5,285 | 3 |
| , MD | Orthopaedic Surgery | Princeton, NJ | $5,207 | 2 |
| , MD | Obstetrics & Gynecology | Livingston, NJ | $5,095 | 2 |
| , MD | Obstetrics & Gynecology | Boston, MA | $5,043 | 2 |
| , M.D | Urogynecology and Reconstructive Pelvic Surgery | Orlando, FL | $4,899 | 2 |
| , MD | Orthopaedic Surgery | Wellington, FL | $4,434 | 2 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Virginia Beach, VA | $4,200 | 1 |
| Mark Snyder | — | Cincinnati, OH | $4,169 | 1 |
| Stanley Dysart | — | Marietta, GA | $4,167 | 2 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Denver, CO | $3,957 | 1 |
| , M.D | Obstetrics & Gynecology | Paterson, NJ | $3,796 | 2 |
| , M.D | Obstetrics & Gynecology | Pottstown, PA | $3,666 | 2 |
| , M.D | Surgery | Chicago, IL | $3,535 | 1 |
| , MD | Orthopaedic Surgery | Charlotte, NC | $3,510 | 1 |
| , DO | Surgery | Greenville, SC | $3,500 | 2 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Birmingham, AL | $3,375 | 1 |
| , D.O | Orthopaedic Surgery | Manhattan, KS | $3,325 | 2 |
| , M.D | Plastic Surgery | Las Vegas, NV | $3,274 | 3 |
| , MD | Neurological Surgery | Philadelphia, PA | $3,218 | 1 |
| , MD, FACOG, AAAAM | General Practice | South Plainfield, NJ | $3,150 | 1 |
| , M.D | Surgery | Miami, FL | $3,030 | 3 |
| , M.D | Obstetrics & Gynecology | Chandler, AZ | $2,988 | 11 |
| , M.D | Surgical Critical Care | Winston Salem, NC | $2,633 | 1 |
| , MD | Orthopaedic Surgery | Hackensack, NJ | $2,600 | 1 |
Ad
Manufacturing Companies
- Ethicon Inc. $503,745
- Medical Device Business Services, Inc. $461,569
- Ethicon US, LLC $198,913
- Ethicon Endo-Surgery Inc. $4,169
- DePuy Synthes Sales Inc. $583.38
- Mentor Worldwide LLC $394.64
- Johnson and Johnson International $185.10
- Johnson & Johnson Health Care Systems Inc. $19.71
Product Information
- Type Device
- Total Payments $1.2M
- Total Doctors 1,531
- Transactions 2,163
About DERMABOND Portfolio
DERMABOND Portfolio is a device associated with $1.2M in payments to 1,531 healthcare providers, recorded across 2,163 transactions in the CMS Open Payments database. The primary manufacturer is Ethicon Inc..
Payment data is available from 2017 to 2020. In 2020, $467,322 was paid across 328 transactions to 183 doctors.
The most common payment nature for DERMABOND Portfolio is "Consulting Fee" ($947,559, 81.0% of total).
DERMABOND Portfolio is associated with 3 research studies, including "Investigation of a New Skin Closure Device, Dermabond PRINEO, for Total Shoulder Arthroplasty: A Randomized, Controlled Trial (US)" ($60,300).